Interpace Biosciences, Inc. (IDXG) insider trading.
In Q3 2026, insiders at Interpace Biosciences, Inc. reported 3 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 2
- Last filed
- 2026-08-20
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Burnell Thomas W. | Director, Officer · CEO, President & Chairman | 2 | 0 | 0 |
| McCarthy Christopher | Officer · CFO & COO | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | McCarthy Christopher | M (A) | 277,009 | $0 | 323,800 | Form 4 |
| 2026-08-20 | Burnell Thomas W. | F (D) | 581,718 | $1.61 | 1,455,927 | Form 4 |
| 2026-08-20 | Burnell Thomas W. | M (A) | 1,966,763 | $0 | 2,037,645 | Form 4 |
Transaction codes in this quarter
Get IDXG insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1054102&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · IDXG company page · Interpace Biosciences, Inc. on SEC.gov
Questions
Are insiders buying or selling Interpace Biosciences, Inc. (IDXG)?
In Q3 2026, insiders at Interpace Biosciences, Inc. reported 3 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Interpace Biosciences, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/idxg.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.